Total Payments
$9,864
2024 Payments
$1,151
Companies
37
Transactions
381
Medicare Patients
3,049
Medicare Billing
$285,983
Payment Breakdown by Category
Food & Beverage$9,485 (96.2%)
Consulting$350.00 (3.5%)
Education$29.27 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,485 | 378 | 96.2% |
| Consulting Fee | $350.00 | 1 | 3.5% |
| Education | $29.27 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $1,693 | 39 | $0 (2023) |
| Allergan, Inc. | $934.03 | 40 | $0 (2022) |
| ABBVIE INC. | $872.08 | 34 | $0 (2024) |
| Galderma Laboratories, L.P. | $515.94 | 27 | $0 (2023) |
| Janssen Biotech, Inc. | $445.37 | 26 | $0 (2022) |
| Medimetriks Pharmaceuticals, Inc. | $433.87 | 6 | $0 (2018) |
| PFIZER INC. | $427.29 | 19 | $0 (2024) |
| LEO Pharma Inc. | $408.25 | 17 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $376.53 | 12 | $0 (2024) |
| Lilly USA, LLC | $353.95 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,151 | 44 | ABBVIE INC. ($381.53) |
| 2023 | $832.98 | 37 | Amgen Inc. ($173.45) |
| 2022 | $1,477 | 41 | Merz North America, Inc. ($487.05) |
| 2021 | $1,209 | 55 | Allergan, Inc. ($267.30) |
| 2020 | $645.45 | 21 | MERZ NORTH AMERICA, INC. ($277.07) |
| 2019 | $2,211 | 81 | Merz North America, Inc. ($588.56) |
| 2018 | $871.74 | 46 | Galderma Laboratories, L.P. ($112.00) |
| 2017 | $1,466 | 56 | Medimetriks Pharmaceuticals, Inc. ($421.79) |
All Payment Transactions
381 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/23/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/05/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $46.39 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/30/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/13/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $36.57 | General |
| Category: Dermatology | ||||||
| 07/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.99 | General |
| Category: Dermatology | ||||||
| 06/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/30/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Inflammation & Immunology | ||||||
| 05/26/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Immunology | ||||||
| 05/10/2024 | Haemonetics Corporation | TEG6S HEMOSTASIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $89.59 | General |
| Category: DEVICES | ||||||
| 05/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $136.41 | General |
| 05/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 758 | 1,625 | $160,408 | $68,252 |
| 2022 | 12 | 934 | 1,881 | $201,478 | $90,652 |
| 2021 | 10 | 704 | 1,702 | $150,508 | $68,848 |
| 2020 | 10 | 653 | 1,517 | $132,136 | $58,231 |
Total Patients
3,049
Total Services
6,725
Medicare Billing
$285,983
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 311 | $51,026 | $21,702 | 42.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 79 | 97 | $21,760 | $10,206 | 46.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 136 | 213 | $27,385 | $10,014 | 36.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 74 | 91 | $18,182 | $7,106 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 64 | $14,685 | $6,451 | 43.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 106 | 726 | $9,705 | $4,897 | 50.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 73 | $8,202 | $3,584 | 43.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 11 | $3,587 | $1,743 | 48.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,916 | $1,525 | 38.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 20 | $1,960 | $1,024 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 222 | 316 | $51,208 | $22,869 | 44.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 108 | 134 | $29,397 | $13,555 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 105 | $23,987 | $12,178 | 50.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 172 | 253 | $31,983 | $11,531 | 36.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 91 | 105 | $20,872 | $9,023 | 43.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 123 | 803 | $10,664 | $5,498 | 51.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 15 | 17 | $10,027 | $5,244 | 52.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 52 | 63 | $6,449 | $2,778 | 43.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $5,566 | $2,552 | 45.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 13 | 16 | $5,150 | $2,544 | 49.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 18 | 30 | $2,945 | $1,567 | 53.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,231 | $1,313 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 181 | 291 | $46,971 | $20,863 | 44.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 132 | 234 | $28,724 | $11,027 | 38.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 77 | 94 | $20,310 | $10,321 | 50.8% |
About Dr. Ashley Smith, MD
Dr. Ashley Smith, MD is a Dermatology healthcare provider based in Sausalito, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053579979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Smith, MD has received a total of $9,864 in payments from pharmaceutical and medical device companies, with $1,151 received in 2024. These payments were reported across 381 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($9,485).
As a Medicare-enrolled provider, Smith has provided services to 3,049 Medicare beneficiaries, totaling 6,725 services with total Medicare billing of $285,983. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology, Procedural Dermatology
- Location Sausalito, CA
- Active Since 05/28/2008
- Last Updated 04/30/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053579979
Products in Payments
- XEOMIN (Biological) $583.37
- BOTOX (Biological) $523.47
- Neo-Synalar Cream Kit (Drug) $395.70
- TALTZ (Drug) $353.95
- Otezla (Drug) $342.88
- XTRAC (Device) $323.08
- DAXXIFY (Drug) $317.54
- REMICADE (Biological) $275.42
- Xeomin (Biological) $261.67
- COSENTYX (Biological) $251.98
- CIBINQO (Drug) $239.14
- EPIDUO FORTE (Drug) $227.12
- KERYDIN (Drug) $204.51
- ADBRY (Biological) $188.88
- EUCRISA (Drug) $188.15
- Humira (Biological) $181.86
- DUPIXENT (Biological) $175.26
- OPZELURA (Drug) $164.66
- SKYRIZI (Biological) $156.80
- ENSTILAR (Drug) $150.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.